CPH2 has delivered Ireland’s first-ever electrolyser. The MFE02 Containerised Membrane-Free Electrolyser™ was shipped from CPH2's Technology Innovation Centre in Doncaster, commissioned, and is ready to produce pure hydrogen and medical grade oxygen.
At the same time, Jon Duffy, Chairman, and CEO has been engaged with private investors to secure a further £3m of funds.
Jon Duffy said, "This new investment will help us to scale the business further to meet the rapid growth and demand of the global electrolyser market, as well as the continued development of our manufacturing processes.”
The CPH2 system produces a mixed gas that is cryogenically separated. It makes use of a highly efficient heat exchanger to recover the cold energy invested in the distillation of the oxygen from the mixed gas stream, and this process renders the separation highly efficient. The CPH2 safety philosophy ensures complete safety for operators and components alike, unlike membrane-separated technology systems such as PEM and Alkaline, where membrane failure can lead to undetected mixing of gases and consequential catastrophic ignition.
Development Director Ian Pillay said, “This is such a momentous occasion for the company. The team has worked tirelessly to get to this point. They have put in exceedingly long days and weekends to ensure that we are ready on time. Not even COVID-19 has stopped us, and I am extremely proud of what we have achieved."
Alongside this successful deployment, CPH2 is currently building MFE220 1MW electrolysers, MFE30, and MFE30+ electrolysers for delivery mid-2021. With continued investment in R&D, CPH2 aims to advance the levels of efficiency and operating costs to a new level, enabling the company to maintain the position of offering the lowest lifetime cost of hydrogen.
Don't miss out on our latest news, updates and events - sign up here.